Todd R. Ryder
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Ion channel regulation and function, Amino Acid Enzymes and Metabolism
Most-Cited Works
- → Discovery of (R)-2-Amino-6-borono-2-(2-(piperidin-1-yl)ethyl)hexanoic Acid and Congeners As Highly Potent Inhibitors of Human Arginases I and II for Treatment of Myocardial Reperfusion Injury(2013)85 cited
- → Characterization of TAP Ambr 250 disposable bioreactors, as a reliable scale‐down model for biologics process development(2016)79 cited
- → Synthesis of a Series of 4-Benzyloxyaniline Analogues as Neuronal N-Type Calcium Channel Blockers with Improved Anticonvulsant and Analgesic Properties(1999)41 cited
- → Synthesis of quaternary α-amino acid-based arginase inhibitors via the Ugi reaction(2013)40 cited
- → A Scalable Total Synthesis of (−)-Nakadomarin A(2016)37 cited
- → Pharmacokinetics and Disposition of the Thiouracil Derivative PF-06282999, an Orally Bioavailable, Irreversible Inactivator of Myeloperoxidase Enzyme, Across Animals and Humans(2015)32 cited
- → The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases(2005)32 cited
- → 2-Substituted-2-amino-6-boronohexanoic acids as arginase inhibitors(2013)31 cited
- → Rapid optimization of an ice inhibitor synthesis using multiple reaction conditions in a parallel array(1998)31 cited
- → The discovery of [1-(4-dimethylamino-benzyl)-piperidin-4-yl]-[4-(3,3-dimethylbutyl)-phenyl]-(3-methyl-but-2-enyl)-amine, an N-type Ca+2 channel blocker with oral activity for analgesia(2000)29 cited